By DAVID GELLES
Allergan, the Botox maker fending off a hostile takeover attempt by Valeant Pharmaceuticals and Pershing Square Capital Management, set Dec. 18 as the meeting date, though it could be derailed before then.
Published: August 26, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1rylWTi
from WordPress http://ift.tt/1qrvJb8
via Hadi Aboukhater
No comments:
Post a Comment